Product Liability 2009 - Arnold & Porter LLP
Product Liability 2009 - Arnold & Porter LLP
Product Liability 2009 - Arnold & Porter LLP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Korea<br />
206<br />
Lee & Ko Korea<br />
In case of breach of contract claims, the claimant would bear the<br />
burden of proving that the manufacturer had breached the contract<br />
due to its supply of products not conforming to the terms of the<br />
contract, and as a result, the claimant had suffered damages.<br />
2.2 What test is applied for proof of causation? Is it enough<br />
for the claimant to show that the defendant wrongly<br />
exposed the claimant to an increased risk of a type of<br />
injury known to be associated with the product, even if it<br />
cannot be proved by the claimant that the injury would<br />
not have arisen without such exposure?<br />
The standard of causation is not specifically provided for under the<br />
PLA. However, the recent trend by the Korean courts is to shift the<br />
burden of proof to the defendants regarding the existence of defect and<br />
causation. For instance, the consumer would only need to prove that<br />
the accident were to happen within the realm of manufacturer’s<br />
control and the accident would generally not happen without<br />
someone’s fault. If the consumer proves such facts, then the court<br />
would presume that the product was defective and the damage was<br />
caused by such defect to alleviate the burden of consumers. Further,<br />
the wrongful exposure of a claimant to an increased risk of injury that<br />
is known to be associated with the product alone would not make the<br />
manufacturer liable for damages, unless some sort of injury such as<br />
physical or mental injury is proved by the claimant.<br />
2.3 What is the legal position if it cannot be established which<br />
of several possible producers manufactured the defective<br />
product? Does any form of market-share liability apply?<br />
Market-share liability is not recognised under Korean law. In order<br />
to impose product liability, the manufacturer of the defective<br />
product would need to be identified. In case the manufacturer<br />
cannot be identified, the supplier or lesser might be liable under<br />
certain requirements (please see question 1.3).<br />
2.4 Does a failure to warn give rise to liability and, if so, in<br />
what circumstances? What information, advice and<br />
warnings are taken into account: only information provided<br />
directly to the injured party, or also information supplied to<br />
an intermediary in the chain of supply between the<br />
manufacturer and consumer? Does it make any difference<br />
to the answer if the product can only be obtained through<br />
the intermediary who owes a separate obligation to assess<br />
the suitability of the product for the particular consumer,<br />
e.g. a surgeon using a temporary or permanent medical<br />
device, a doctor prescribing a medicine or a pharmacist<br />
recommending a medicine? Is there any principle of<br />
“learned intermediary” under your law pursuant to which<br />
the supply of information to the learned intermediary<br />
discharges the duty owed by the manufacturer to the<br />
ultimate consumer to make available appropriate product<br />
information?<br />
As abovementioned in question 2.2, the PLA requires reasonable<br />
explanation, instruction, warning, and other indications regarding<br />
the product directly for the consumer. The learned intermediary<br />
defence would not be recognised by Korean courts.<br />
3 Defences and Estoppel<br />
3.1 What defences, if any, are available?<br />
Affirmative defences may be proved by manufacturers in product<br />
liability suits to be exempted from liability:<br />
(1) the claim was brought beyond the 3- or 10-year statute of<br />
limitation;<br />
(2) the manufacturer did not supply the product;<br />
(3) the state of scientific or technical knowledge at the time<br />
when the manufacturer supplied the product was not such as<br />
to enable the existence of the defect to be discovered;<br />
(4) the defect in the product is due to compliance with applicable<br />
laws at the time when the manufacturer supplied it; or<br />
(5) (in case of subcontractor) the components or raw materials<br />
claimed to be the cause of the defect were supplied pursuant<br />
to the specifications and instructions given by the final<br />
manufacturer.<br />
However, where, in spite of the fact that the manufacturer knows or<br />
should have known the existence of any defect in the product after<br />
it has been supplied, the manufacturer fails to take appropriate<br />
measures to prevent the damage caused by the defect from<br />
occurring, then the manufacturer shall not enjoy from exemptions<br />
#3 and #5 above (Article 4 of the PLA).<br />
Further, if the negligent actions of the claimant contributed to the<br />
overall damage, then the amount of damage compensation<br />
attributable to such negligence of the claimant may be deducted<br />
(please see question 3.6).<br />
3.2 Is there a state of the art/development risk defence? Is<br />
there a defence if the fault/defect in the product was not<br />
discoverable given the state of scientific and technical<br />
knowledge at the time of supply? If there is such a<br />
defence, is it for the claimant to prove that the fault/defect<br />
was discoverable or is it for the manufacturer to prove that<br />
it was not?<br />
As abovementioned in question 3.1(3), a “state of scientific or<br />
technical knowledge” defence is recognised under the PLA. The<br />
manufacturer would have the burden of proving that the state of<br />
scientific or technical knowledge at the time when the manufacturer<br />
supplied the product was not such as to enable the existence of the<br />
defect to be discovered.<br />
3.3 Is it a defence for the manufacturer to show that he<br />
complied with regulatory and/or statutory requirements<br />
relating to the development, manufacture, licensing,<br />
marketing and supply of the product?<br />
As abovementioned in question 3.1(4), in case the defect in the<br />
product is due to compliance with applicable laws at the time when<br />
the manufacturer supplied it, and the manufacturer asserts this<br />
affirmative defence, liability may be avoided. However, this<br />
affirmative defence may only be applied in case where the<br />
government has mandated certain regulatory standard onto the<br />
manufacturer and the manufacturer had no other choice but to<br />
comply with such regulatory standard. Meaning, a mere showing<br />
of the manufacturer’s compliance with minimum regulatory<br />
standards does not provide for this defence under the PLA.<br />
3.4 Can claimants re-litigate issues of fault, defect or the<br />
capability of a product to cause a certain type of damage,<br />
provided they arise in separate proceedings brought by a<br />
different claimant, or does some form of issue estoppel<br />
prevent this?<br />
A claim for damages due to a defective product can be re-litigated<br />
even if the issues have been contested and finally resolved in<br />
different cases, because the effectiveness of final judgement covers<br />
only the parties to the litigation under Korean law. However, in<br />
WWW.ICLG.CO.UK<br />
ICLG TO: PRODUCT LIABILITY <strong>2009</strong><br />
© Published and reproduced with kind permission by Global Legal Group Ltd, London